News

Antibodies you can eat: A therapeutic revolution from the Callewaert lab and collaborators
10 August 2019
VIB-UGent, VIB-VUB and UGent labs have developed a new antibody technology that combines the advantages of antibody-based therapies with the convenience of oral drug administration.
Quickscan II
4 August 2019
VIB's scientific publications second quarter 2019
Walter Fiers, founder of VIB and pioneer of biotechnology in Flanders, passed away
30 July 2019
Walter Fiers, one of the founders of VIB and an exceptional scientist, passed away on July 28th, 2019.
To become, or not to become... a neuron
25 July 2019
Researchers led by Pierre Vanderhaeghen and Jérôme Bonnefont (VIB-KU Leuven and ULB) have unraveled a new mechanism controlling the switch between growth and differentiation of neural stem cells during brain development.
European scientists ask the EU Parliament and EU Commission reconsider genome editing for sustainable agriculture and food production
25 July 2019
One year ago, the ECJ unfortunately took a tough stand on genome editing with its strict legal decision. The European scientific community, representing 124 plant research institutes across Europe, now urges policy makers to reconsider their verdict
Open Statement for the use of genome editing for sustainable agriculture and food production in the EU
25 July 2019
European scientists urgently reach out to the newly elected European Parliament and European Commission to enable the potential of genome editing for sustainable agriculture and food production.
In conversation with Peter Piot, one of the new members of VIB’s Institutional Advisory Board
24 July 2019
The IAB consists of prominent international scientists and managers who regularly formulate recommendations to VIB on its institutional policy and the board will be joined by three new IAB members. Peter Piot starts as of 2019,
FFAR Grant to USDA-ARS Bolsters Soybean Resiliency to Climate Change
22 July 2019
Scientists from USDA-ARS , NCSA & team of Ive De Smet (VIB-UGent) will use advanced machine learning algorithms to leverage natural genetic diversity of plants and improve sustainability, nutrition & flavor profiles of crops with greater precision.
Waking up sleeping bacteria to fight infections
18 July 2019
Researchers in the group of Jan Michiels (VIB-KU Leuven Center for Microbiology) identified a mechanism of how sleepy bacteria wake up. This finding is important, as sleepy cells are often responsible for the stubbornness of chronic infections.
Acknowledging the core of progress
15 July 2019
VIB invests strongly in core facilities that enable the life scientists to access the newest technologies. Beyond access, the core facilities’ staff ensures the presence of the know-how needed to operate these platforms.
Stripping down bacterial armor: a new way to fight anthrax
15 July 2019
A new study led by Antonella Fioravanti in the lab of Han Remaut (VIB-VUB Center for Structural Biology) has shown that removing the armor of the bacterium that causes anthrax slows its growth and negatively affects its ability to cause disease.
The ambitious American StixFresh finds necessary R&D expertise in Leuven
15 July 2019
The American company launches a Belgian subsidiary and initiates an R&D facility in Leuven to collaborate with Patrick Van Dijck (VIB-KU Leuven). He is one of the few researchers globally who could bring the necessary expertise to bear.
Using ketone bodies in the fight against lymphedema
12 July 2019
The administration of ketone bodies stimulates the growth of lymph vessels & has substantial beneficial effects in conditions affecting the lymphatic system. These spectacular positive effects were found by group of Peter Carmeliet (VIB-KU Leuven)
Ajit Shetty, chairman of VIB’s board of directors, receives the ‘Ereteken van de Vlaamse Gemeenschap’
10 July 2019
Each year, the Flemish government bestows awards upon certain individuals. These ‘Eretekens’ are a tribute to people who have proven themselves exceptionally serviceable for Flanders & who made great contributions to international prestige of the region.
Molecular machines and evolutionary riddles: The savvides group Elucidates both
9 July 2019
A research team from Savvas Savvides’ lab in the VIB-UGent Center for Inflammation Research, led by Kenneth Verstraete, has unraveled the three-dimensional structure and molecular mechanism of ATP citrate lyase (ACLY).

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 Next»

Get news updates:

Email updates
Follow us on Twitter
Like us on Facebook
RSS